Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Automation In Biopharma Industry Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The market for automation within the biopharma industry has shown strong growth in recent years. It is projected to expand from $2.19 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this growth can be ascribed to the increasing complexity of biologic drug production, rising demand for scalable biopharma manufacturing, early adoption of laboratory automation, expansion of contract manufacturing services, and advancements in process control technologies.
The market size for automation within the biopharma industry is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $3.16 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This projected growth during the forecast timeframe is primarily driven by factors such as a rise in investments towards intelligent biomanufacturing setups, wider acceptance of continuous manufacturing processes, an increase in personalized biologics production, a heightened need for automation that complies with regulations, and a greater emphasis on enhancing manufacturing efficiency. Key trends anticipated during this period encompass the increasing deployment of robotic manufacturing platforms, the growing incorporation of digital twin technologies, an expanded application of automated quality control systems, the broadening of complete end-to-end bioprocess automation, and a sharpened focus on manufacturing approaches guided by data.
Get A Free Sample Report With In-Depth Market Insights:
Automation In Biopharma Industry Market Development Factors: What’s Supporting Demand?
The growing integration of robotic systems within pharmaceutical manufacturing facilities is anticipated to fuel the expansion of the automation in biopharma industry market. These robots represent sophisticated automated systems and machinery designed to execute diverse functions in the production and packaging of pharmaceutical goods. Their deployment spans numerous applications within pharmaceutical manufacturing, including secondary packaging, intralogistics, laboratory automation, pick and place operations, pharmacy process automation, and personalized medicine. This adoption leads to benefits such as increased productivity, improved precision, minimized contamination risk, and heightened worker safety. A notable example is provided by the International Federation of Robotics, a Germany-based professional non-profit organization, which reported that in September 2024, industrial robot installations across the European manufacturing industry climbed by 9%, setting a new peak at 92,393 units. Within this total, 80% were deployed specifically within the European Union, amounting to 73,534 units, which signifies a 2% increase compared to the prior year. Consequently, the expanding use of robots in pharmaceutical manufacturing is poised to propel the growth of the automation in biopharma industry market.
Automation In Biopharma Industry Market Segmentation: How Does The Market Break Down By Category?
The automation in biopharma industry market covered in this report is segmented –
1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase
Subsegments:
1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology
Automation In Biopharma Industry Market Transformation Trends: What Innovations Are Driving Change?
Leading firms in the biopharma industry market are implementing automation, with an emphasis on creating advanced technologies like robotic cell-therapy manufacturing platforms to achieve scalable, efficient, and error-reduced production of cutting-edge therapies. Such a robotic cell-therapy manufacturing platform integrates mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control into an entirely closed and modular setup, thereby superseding conventional manual bioprocessing that typically depends on extensive labor and open systems. An example of this is Cellular Origins, a UK-based life sciences automation company, which introduced Constellation, a customizable robotic platform designed for advanced therapy manufacturing, in May 2023. This platform incorporates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, facilitating smooth incorporation into current bioprocessing workflows. It enhances space efficiency by 30 times, decreases labor needs by 16-fold, and lowers production costs by 51%, while also providing complete digital interconnection for quality control and remote monitoring.
Automation In Biopharma Industry Market Competitive Overview And Top Companies
Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.
View The Full Automation In Biopharma Industry Market Report:
Automation In Biopharma Industry Market Top Region By Revenue And Market Share
North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









